- Home
- RY vs SYK Comparison
RY vs SYK Comparison
Compare RY & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RY
- SYK
- Stock Information
- Founded
- RY 1864
- SYK 1941
- Country
- RY Canada
- SYK United States
- Employees
- RY N/A
- SYK N/A
- Industry
- RY
- SYK Medical/Dental Instruments
- Sector
- RY
- SYK Health Care
- Exchange
- RY Nasdaq
- SYK Nasdaq
- Market Cap
- RY 159.6B
- SYK 139.3B
- IPO Year
- RY N/A
- SYK N/A
- Fundamental
- Price
- RY $119.86
- SYK $382.45
- Analyst Decision
- RY Strong Buy
- SYK Buy
- Analyst Count
- RY 2
- SYK 19
- Target Price
- RY $156.50
- SYK $424.28
- AVG Volume (30 Days)
- RY 1.2M
- SYK 1.6M
- Earning Date
- RY 05-29-2025
- SYK 05-01-2025
- Dividend Yield
- RY 3.43%
- SYK 0.88%
- EPS Growth
- RY 16.08
- SYK N/A
- EPS
- RY 8.49
- SYK 7.40
- Revenue
- RY $39,472,538,730.00
- SYK $23,218,000,000.00
- Revenue This Year
- RY $22.14
- SYK $9.78
- Revenue Next Year
- RY $3.42
- SYK $7.53
- P/E Ratio
- RY $14.11
- SYK $51.69
- Revenue Growth
- RY 16.96
- SYK 10.76
- 52 Week Low
- RY $101.96
- SYK $314.93
- 52 Week High
- RY $128.05
- SYK $406.19
- Technical
- Relative Strength Index (RSI)
- RY 59.30
- SYK 61.98
- Support Level
- RY $117.43
- SYK $363.08
- Resistance Level
- RY $121.73
- SYK $383.99
- Average True Range (ATR)
- RY 1.54
- SYK 8.72
- MACD
- RY 0.22
- SYK 3.36
- Stochastic Oscillator
- RY 73.66
- SYK 89.12
About RY Royal Bank Of Canada
Royal Bank of Canada is one of the two largest banks in Canada, with over CAD 2 trillion in assets. It is a diversified financial services company, offering personal and commercial banking, wealth management, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada and has dominant market shares. RBC also has wealth and capital market businesses in the US, UK, and other countries. RBC is a top 15 investment bank globally.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.